Latest News for CDIO
Sutro Biopharma (NASDAQ: STRO - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability. Profitability This table compares Sutro Biopharma and
[url="]Cardio Diagnostics Holdings, Inc.[/url] (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the release of a new edit
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has released a new edition of the company's rural health report: The State of Rural Hospitals and Cardiovascular Care.
Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CDIO.
U.S. House Trading
No House trades found for CDIO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.